Ledipasvir & Sofosbuvir-Hepcinat Lp

Shubham Pharmacuiticals
Ledipasvir & Sofosbuvir-Hepcinat Lp
Product Code : 100
 
Product Description

LEDIPASVIR & SOFOSBUVIR:

HEPCINAT-LP contains the Drug / Molecules Ledipasvir & Sofosbuvir.

 

USAGE & DESCRIPTION :

HEPCINAT-LP has used for the treatment of chronic hepatitis C virus (HCV). 

ACTIVE INGREDIENTS

LEDIPASVIR(90MG)& SOFOSBUVIR(400MG)

BRAND NAME

HEPCINAT- LP

INTERNATIONAL BRAND NAME

SOVALDI

PACKING

1*28

DOSES FORM

TABLETS (IN PLASTIC BOTTLE)

STRENGTH

90MG+400 MG

MFG BY

NATCO PHARMA LIMITED. (INDIA) UNDER LICENSE FROM GILEAD SCIENCE IRELAND UC

CLINICAL APPLICATIONS :

Hepcinate LP is a fixed-dose combination of ledipasvir and sofosbuvir which are direct acting antiviral agents against the hepatitis C virus (HCV). Ledipasvir is an inhibitor of the protein, which is required for viral replication. Sofosbuvir is a nucleotide prodrug that undergoes intracellular metabolism to form the pharmacologically active uridineanalog triphosphate which can be incorporated into HCV RNA and acts as a chain terminator .

 

STORAGE :

Store at a temperature not exceeding 30°C.

 
Trade Information
  • Main Export Market(s)
  • Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia